PP
AGTC

Paloma Partners’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Paloma Partners’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-47,600
Closed -$243K – 2550
2017
Q2 		$243K Buy
+47,600
New +$267K ﹤0.01% 1901

Other funds holding AGTC

IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Paloma Partners's AGTC Position: Q3 2017 in Review

Paloma Partners sold out of Applied Genetic Technologies Corporation (AGTC) in Q3 2017, closing a stake of 47,600 shares — an estimated $243K sold.

Paloma Partners first reported a position in AGTC in Q2 2017 and held it in 1 quarter. The position peaked at $243K in Q2 2017. 67 funds tracked by Wall St. Rank hold AGTC as of Q3 2017.

  • Paloma Partners reported no remaining Applied Genetic Technologies Corporation position as of Q3 2017 after selling out during the quarter.
  • Paloma Partners sold 47,600 Applied Genetic Technologies Corporation shares in Q3 2017, an estimated $243K.
  • Paloma Partners first reported a position in Applied Genetic Technologies Corporation in Q2 2017 and held it in 1 quarter.
  • Paloma Partners's Applied Genetic Technologies Corporation position peaked at $243K in Q2 2017.
  • 67 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q3 2017.

Based on Paloma Partners's 13F filing for Q3 2017, filed 14 Nov 2017.